Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07337538 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Two Mini-implant Diameters in the Infra-zygomatic Crest Region.

Study acronym: TADs
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 5 more changesShow less
    • Primary completion date changed from estimate of Sep 1, 2026 to Jul 3, 2026
    • Study sites: 2 to 1
    • Study completion date: Nov 1, 2026 to Nov 3, 2026
    • Secondary endpoints: details revised at 1 of 2 entries
    • Eligibility criteria expanded, about 5 words
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 20, 2026 to Jan 14, 2026
    • Secondary endpoints: details revised at 1 of 2 entries
    • Site details revised at 2 of 2 sites
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trials is to compare two diameters, 1.6 and 2 mm, of mini implants both are 12 mm length placed in the infrazygomatic crest region. The main questions it aims to answer are: which diameter is more suitable for IZC region 1.6 or 2mm in terms of primary stability, secondary stability, pain perception and failure rate. 20 participant will receive 40 mini implant bilaterally (20 in one side of 1.6mm, the other side 20 of 2mm). participants will be asked to record visual analog scale (VAS) for 3 nights monitored monthly by the investigator.
Trial Details
NCT Number NCT07337538
Lead Sponsor University of Baghdad
Conditions
(from sponsor)		 Implant Stability
Related terms Tietz syndrome
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov